Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple-combination valsartan + hydrochlorothiazide + amlodipine versus dual combinations in moderate to severe hypertension
2006-000774-70Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of valsartan, hydrochlorothiazide and amlodipine in hypertension (HTN) (4 arms), sponsored by Novartis. Primary endpoints: Change from baseline in mean sitting diastolic blood pressure and Blood pressure control rate. Started Apr 2006; status: completed.
02
Drugs
valsartanhydrochlorothiazideamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2006-000774-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000774-70.